Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes

Nature Biotechnology

Volumn 15, Issue 9, 1997, Pages 882-886

  Xiong, Sidong ^a   Gerloni, Mara ^a   Zanetti, Maurizio ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Antibody engineering; Rational protein design; Vaccine design

Indexed keywords

B LYMPHOCYTE ANTIBODY; EPITOPE; PROTOZOON ANTIBODY; T LYMPHOCYTE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; GENE EXPRESSION; GENETIC ENGINEERING; IMMUNIZATION; IMMUNOGLOBULIN GENE; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY FORMATION; ANTIGENS, PROTOZOAN; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; GENE EXPRESSION REGULATION; GENES, IMMUNOGLOBULIN; GENETIC ENGINEERING; INTERLEUKIN-2; MICE; OLIGOPEPTIDES; PLASMIDS; PLASMODIUM FALCIPARUM; PROTOZOAN VACCINES; SPLEEN; TRANSFECTION; TRANSGENES;

ANIMALIA; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0030828486     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0997-882     Document Type: Article

References (43)

1. Zanetti, M. 1992. Antigenized antibodies. Nature 355:466-477.
2. Zanetti, M., Rossi, F., Lanza, P., Filaci, G., Lee, R.H., and Billetta, R. 1992. Theoretical and practical aspects of antigenized antibodies. Immunol. Rev. 130:125-150.
3. Sollazzo, M., Billetta, R., and Zanetti, M. 1990. Expression of an exogenous peptide epitope genetically engineered in the variable domain of an immunoglobulin: Implications for antibody and peptide folding. Prot. Engineer. 4:215-220.
4. Billetta, R., Hollingdale, R.M., and Zanetti, M. 1991. Immunogenicity of an engineered internal image antibody. Proc. Natl. Acad. Sci. USA 88:4713-4717.
5. Lanza, P., Billetta, R., Antonenko, S., and Zanetti, M. 1993. Active immunity against the CD4 receptor using an antibody antigenized with residues 41-55 of the first extracellular domain. Proc. Natl. Acad. Sci. USA 90:11683-11687.
6. Zaghouani, H., Anderson, S.A., Sperber, K.E., Daian, C., Kennedy, R.C., Mayer, L., and Bona C.A. 1995. Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein. Proc. Natl. Acad. Sci. USA 92:31-635.
7. Zaghouani, H., Steinman, R., Nonacs, R., Shah, H., Gerhard, W., and Bona, C. 1993. Presentation of a viral T cell epitope expressed In the CDR3 region of a self immunoglobulin molecule. Science 259:224-227.
8. Billetta, R., Filaci, G., and Zanetti, M. 1995. Major histocompatibility complex class I-restricted presentation of influenza virus nucleoprotein peptide by B lymphoma cells harboring an antibody gene antigenized with the virus peptide. Eur. J. Immunol. 25:776-783.
9. Xiong, S., Gerloni, M., and Zanetti, M. 1997. In vivo role of B lymphocytes in somatic transgene Immunization. Proc. Natl. Acad. Sci. USA 94:6352-6357.
10. Gerloni, M., Billetta, R., Xiong, S., and Zanetti, M. 1997. Somatic transgene Immunization with DNA encoding an immunoglobulin heavy chain. DNA Cell. Biol. 16:611-625.
11. Gerloni, M., Ballou, W.R., Billetta, R., and Zanetti, M. 1997. Immunity to Plasmodium falciparum sporozoites by somatic transgene immunization. Nature Biotechnology 15:876-881.
12. Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H., Felgner, P.L., Dwarki, V.J., et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
13. Wang, B., Ugen, K., Srikantan, V., Agadjanyan, M., Dang, K., Refaeli, Y., et al. 1993. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:4156-4160.
14. Raz, E., Carson, D.A., Parker, S.E., Parr, T.B., Abal, A.M., Aichinger, G., et al. 1994. Intradermal gene Immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 91:9519-9523.
15. Sedegah, M., Hedstrom, R., Hobart, P., and Hoffman, S.L. 1994. Protection against malaria by Immunization with Plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866-9870.
16. Davis, H.L., Michel, M.L., Mancini, M., Schleef, M., and Whalen, R.G. 1994. Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine 12:1503-1509.
17. Conry, R.M., LoBuglio, A.F., Kantor, J., Schlom, J., Loechel, F., Moore, S.E., et al. 1994. Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res. 54:1164-1168.
18. Fynan, E.F., Webster, R.G., Fuller, D.H., Haynes, J.R., Santoro, J.C., and Robinson, H.L. 1993. DNA vaccines: protective immunizations by parenteral, mucosal and gene-gun inoculations. Proc. Watt Acad. Sci. USA 90:11478-11482.
19. Eisenbraun, M.D., Fuller, D.H., and Haynes, J.R. 1993. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol. 12:791-797.
20. Mitchison, N.A. 1971. The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation. Eur. J. Immunol. 1:18-27.
21. Herrington, D.A., Clyde, D.F., Losonsky, G., Cortesia, M., Murphy, J.R., Davis, J., et al. 1987. Safety and Immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature 328:257-259.
22. Tam, J.P. and Lu, Y.A. 1989. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes. Proc. Natl. Acad. Sci. USA 88:9084-9088.
23. Tam, J.P., Clavijo, P., Lu, Y.A., Nussenzweig, V., Nussenzweig, R.S., and Zavala, F. 1990. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J. Exp. Med. 171:299-306.
24. Munesinghe, D.Y, Clavijo, P., Calle, M.C., Nussenzweig, R.S., and Nardin, E. 1991. Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein. Eur. J. Immunol. 21:3015-3020.
25. Ballou, W.R., Hoffman, S.L., Sherwood, J.A., Hollingdale, M.R., Neva, F.A., Hockmeyer, W.T., et al. 1987. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet 1:1277-1281.
26. Herrington, D.A., Losonsky, G.A., Smith, G., Volvovitz, F., Cochran, M., Jackson, K., et al. 1992. Safety and Immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells. Vaccine 10:841-846.
27. Zavala, F., Tam, J.P., Hollingdale, M.R., Cochrane, A.H., Quakyi, I., Nussenzweig, R.S., and Nussenzweig, V. 1985. Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science 228:1436-1440.
28. Nardin, E.H., Herrington, D.A., Davis, J., Levine, M., Stuber, D., Takacs, B., et al. 1989. Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer. Science 246:1603-1606.
29. Sollazzo, M., Castiglla, D., Billetta, R., Tramontano, A., and Zanetti, M. 1990. Structural definition by antibody engineering of an idiotypic determinant. Prot. Engineer. 3:531-539.
30. Rigaudy, P., Simon, S., Hunter, T., Sollazzo, M., Billetta, R., Zanetti, M., et al. 1994. Antibodies specific for the neuronal form of the scr protein elicited by an antigenized antibody. DNA Cell Biol. 13:585-591.
31. Morrison, S. 1985. Transfeotomas provide novel chimeric antibodies. Science 229:1202-1207.
32. Billetta, R. and Zanetti, M. 1992. Ligand expression using antigenization of antibody: Principle and methods. ImmunoMethods 1:41-51.
33. Togna, A.R., Del, G.G., Verdini, A.S., Bonelli, F., Pessi, A., Engers, H.D., and Corradin, G. 1986. Synthetic Plasmodium falciparum circumsporozoite peptides elicit heterogenous L3T4+ T cell proliferative responses in H-2b mice. J. Immunol. 137:2956-2960.
34. Alzari, P.M., Lacombe, M.-B., and Poljak, R.J. 1988. Three-dimensional structure of antibodies. Ann. Rev. Immunol. 6:555-580.
35. Kabat, E.A., Wu, E.T., Reidmiller, M., Perry, H.M., and Gottesman, K.S. 1987. Proteins of immunological interest. U.S. Department of Health and Human Services, Bethesda, MD.
36. Chothia, C., Lesk, A.M., Tramontano, A., Levitt, M., Smith-Gill, S.J., Air, G., et al. 1989, Conformations of Immunoglobulin hypervariable regions. Nature 342:877-883.
37. Chothia, C. and Lesk, A.M. 1987. Canonical structures for the hypervariable regions of immunoglobulins. J. Mol. Biol. 196:901-917.
38. Poljak, R.J., Amzel, L.M., Avey, H.P., Chen, B.L., Phizackerly, R.P., and Saul, F 1973. Three-dimensional structure of the Fab’ fragment of a human immunoglobulin at 2.8 A resolution. Proc. Natl. Acad. Sci. USA 70:3305-3310 (1973).
39. Sollazzo, M., Hasemann, C.A., Meek, K.D., Glotz, D., Capra, J.D., and Zanetti, M. 1989. Molecular characterization of the VH region of murine autoantibodies from neonatal and adult BALB/c mice. Eur. J. Immunol. 19:453-457.
40. Towbin, H., Staehelin, T., and Gordon, J. 1979. Electrophoretic transfer of proteins from Polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
41. Sambrook, J., Fritsch, E.F., and Maniatis, T. 1989. Molecular cloning: a laboratory manual, 8th ed. Cold Spring Harbor Laboratory Press, Cold Spring, NY.
42. Glasel, J.A. 1995. Validity of nucleic acid purities monitored by 260nm/280nm absorbance ratios. Bio Techniques 18:62-63.
43. Bradley, L.M., Duncan, D.D., Yoshlmoto, K., and Swain, S.L. 1993. Memory effectors: a potent, IL-4-secretlng helper T cell population that develops in vivo after restimulation with antigen. J. Immunol. 150:3119-3130.